• Home
• About
the Chapter
• 
Board
of Directors
• Coding
Information
• CHF
Support Group
• Job
Board
• Legislative
• Meetings
& Events
• News
& Publications
• On-Line
Resources
• Sponsorship
Richard J. Kovacs, MD, FACC
President-Elect
Richard J. Kovacs, MD, FACC
Professor of Clinical Medicine
Krannert Institute of Cardiology
MPC-2 Ste 4000
1801 N Senate Blvd
Indianapolis, IN 46202
Work phone: (317) 962-0142
e-mail: rikovacs@iupui.edu
Dr. Richard Kovacs is Professor of Clinical Medicine at the Indiana University School of Medicine, Krannert Institute of Cardiology. He is a clinical cardiologist and serves as the Clinical Director for the Division of Cardiology at Indiana University. He has a special interest in the cardiac safety of non-cardiac drugs. Dr. Kovacs received his BA from the University of Chicago in 1976 and his MD from the University of Cincinnati in 1980. He was a resident in Internal Medicine at the Indiana University School of Medicine from 1980-1982 and a cardiology fellow at IU from 1982-1985. He served as both Chief Medical Resident and Chief Cardiology Fellow at IU. He joined the IU Cardiology faculty in 1986.
In 1990 he accepted a position as Director of Medical Research at Methodist Hospital of Indiana, and practiced clinical cardiology with Storer Schmidt and Associates. In 2000, he moved to Eli Lilly and Company as Senior Clinical Research Physician where he focused on the assessment of drug safety. He returned to the full time IU faculty in 2003, and continues to consult for Lilly and other organizations interested in drug safety.
Dr. Kovacs has been a Fellow of the American College of Cardiology since 1987. He currently serves as Councilor for the central region of the Indiana Chapter of the ACC. He has served on the National ACC ECG/Pacemaker Committee and chaired various sessions at the ACC Annual Scientific Sessions. He was clinical chair of the International Life Sciences / Health and Environmental Sciences Institute QT study group. Locally, he serves on the hospital Peer Review Committee and Pharmacy and Therapeutics Committee. He has published extensively on the topic of basic cardiac electrophysiology, with a recent emphasis on the ECG evaluation of non-cardiac drugs for proarrhythmia potential.